Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon (Q37001750)

17 August 2017

Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon (English)

1 reference

17 August 2017

0 references

0 references

0 references

A K Njamnshi

1

1 reference

17 August 2017

A C Zoung-Kanyi Bissek

2

1 reference

17 August 2017

P Ongolo-Zogo

3

1 reference

17 August 2017

E N Tabah

4

1 reference

17 August 2017

A Z Lekoubou

5

1 reference

17 August 2017

F N Yepnjio

6

1 reference

17 August 2017

J Y Fonsah

7

1 reference

17 August 2017

C T Kuate

8

1 reference

17 August 2017

S A Angwafor

9

1 reference

17 August 2017

F Dema

10

1 reference

17 August 2017

D M Njamnshi

11

1 reference

17 August 2017

C Kouanfack

12

1 reference

17 August 2017

V de P Djientcheu

13

1 reference

17 August 2017

W F T Muna

14

1 reference

17 August 2017

G D Kanmogne

15

1 reference

17 August 2017

language of work or name

1 reference

24 July 2009

1 reference

17 August 2017

5

1 reference

Journal of the Neurological Sciences

inferred from page(s)

published in

1 reference

17 August 2017

285

1 reference

17 August 2017

1-2

1 reference

17 August 2017

149-153

1 reference

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Quality of life and the impact of drug toxicities in a South African community-based antiretroviral programme

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Second assessment of NeuroAIDS in Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Updated research nosology for HIV-associated neurocognitive disorders

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

The International HIV Dementia Scale: a new rapid screening test for HIV dementia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Management of Anemia of Chronic Disease in Patients with the Human Immunodeficiency Virus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Measuring handedness with questionnaires

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Rationing antiretroviral therapy in Africa--treating too few, too late.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Longitudinal Improvement in Psychomotor Processing Speed Is Associated With Potent Combination Antiretroviral Therapy in HIV-1 Infection

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4906943

Salvage therapy with abacavir and other reverse transcriptase inhibitors for human immunodeficiency-associated encephalopathy

4 September 2018

1 reference

12 December 2020

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

1 reference

12 December 2020

The relationship between age and cognitive function in HIV-infected men

1 reference

12 December 2020

Epidemiology of AIDS Dementia Complex in Europe

1 reference

12 December 2020

Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment

1 reference

12 December 2020

Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance

1 reference

12 December 2020

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

12 December 2020

Highly active antiretroviral therapy improves neurocognitive functioning

1 reference

12 December 2020

Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors

1 reference

12 December 2020

10.1016/J.JNS.2009.06.043

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

19631349

1 reference